CN Stock MarketDetailed Quotes

002198 Guangdong Jiaying Pharmaceutical

Watchlist

7.48
+0.18+2.47%

Not Open Nov 19 15:00 CST

3.80BMarket Cap311.67P/E (TTM)

Guangdong Jiaying Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

105.30%216.89M

-19.54%171.52M

-34.87%118.5M

-27.39%133.51M

-48.89%105.65M

3.21%213.16M

-20.67%181.96M

-23.20%183.86M

-2.75%206.72M

5.89%206.52M

Transactional financial assets

-55.48%80.13M

133.60%140.16M

340.75%220.37M

298.98%200.53M

--180M

--60M

--50M

--50.26M

----

Notes receivable and accounts receivable

-27.11%102.5M

-25.95%111.02M

-36.28%115.57M

-32.57%125.44M

-7.86%140.62M

21.80%149.92M

35.92%181.38M

44.35%186.03M

-4.36%152.61M

-17.52%123.09M

-Notes receivable

-39.04%9.02M

-30.45%12M

-36.17%21.92M

-30.36%27.86M

-40.18%14.8M

-20.34%17.25M

26.50%34.33M

24.98%40.01M

-49.51%24.75M

-49.85%21.65M

-Accounts receivable

-25.70%93.48M

-25.36%99.02M

-36.31%93.66M

-33.17%97.58M

-1.61%125.81M

30.79%132.67M

38.32%147.04M

50.75%146.03M

15.66%127.87M

-4.35%101.44M

Other receivables (including interest and dividends)

59.77%2.52M

314.35%6.65M

-15.05%3.72M

-35.81%2M

-21.45%1.58M

-75.42%1.6M

81.32%4.38M

-23.88%3.12M

-51.91%2.01M

-38.86%6.53M

-Other receivable

----

314.35%6.65M

----

-75.42%1.6M

----

-23.88%3.12M

----

-38.86%6.53M

Advance payment

9.34%24.96M

-90.15%2.3M

12.89%14.81M

-66.06%4.37M

-50.69%22.83M

38.65%23.32M

42.98%13.12M

9.98%12.88M

97.53%46.3M

-4.05%16.82M

Inventories

-5.30%87.16M

20.30%97.43M

7.80%89.94M

2.81%84.6M

17.89%92.04M

-6.61%80.99M

5.37%83.44M

12.17%82.28M

0.52%78.07M

4.26%86.72M

Receivable financing

-70.87%4.11M

-40.00%8.56M

-38.12%19.82M

-25.86%28.6M

-37.08%14.1M

-21.59%14.27M

27.32%32.03M

24.26%38.58M

--22.4M

--18.2M

Other current assets

-83.82%340.93K

-28.42%1.61M

-71.76%492.24K

170.44%1.11M

4,770.97%2.11M

-88.77%2.25M

695.14%1.74M

-65.44%411.65K

-95.23%43.25K

2,010.93%20.05M

Total current assets

-7.21%518.61M

-1.15%539.25M

6.42%583.24M

4.08%580.17M

9.99%558.92M

14.14%545.53M

14.42%548.05M

13.84%557.43M

6.24%508.16M

4.67%477.93M

Non Current assets

Long-term equity investment

-6.83%24.3M

-4.86%25.31M

-8.12%26.13M

-7.78%27.09M

-13.17%26.08M

-13.22%26.61M

-6.94%28.44M

-3.96%29.38M

-42.74%30.03M

-43.76%30.66M

Fixed assets

----

-8.67%181.06M

----

-7.48%198.25M

----

-9.14%203.7M

----

-8.35%214.28M

Constru in process

----

--6.71M

----

Intangible assets

-3.44%46.3M

-5.81%46.55M

-7.89%46.88M

-9.86%47.21M

-10.97%47.95M

-10.67%49.42M

-10.41%50.9M

-10.15%52.37M

-9.89%53.85M

-9.52%55.33M

Long deferred expense

--469.4K

--190.77K

----

Deferred tax assets

12.14%2.44M

16.81%2.55M

-2.17%2.17M

-1.31%2.19M

-51.75%2.18M

-51.81%2.19M

-51.31%2.21M

-51.79%2.21M

-13.46%4.52M

-12.68%4.54M

Other non current assets

--7.44M

--14.42M

-70.97%430.2K

-68.14%493.2K

----

--1.48M

--1.55M

----

--0

Total non current assets

2.54%277.41M

0.12%276.79M

-7.57%261.71M

-7.55%267.39M

-9.26%270.55M

-9.30%276.46M

-8.97%283.14M

-8.95%289.22M

-13.94%298.17M

-14.06%304.81M

Total assets

-4.03%796.01M

-0.72%816.05M

1.66%844.95M

0.11%847.56M

2.87%829.46M

5.01%821.99M

5.21%831.19M

4.87%846.65M

-2.24%806.33M

-3.52%782.74M

Liabilities

Current liabilities

Short term loan

----

--0

Notes payable and accounts payable

-77.54%2.33M

43.62%13.91M

-22.65%12.93M

-51.75%9.16M

-7.87%10.36M

25.73%9.68M

41.35%16.72M

34.35%18.98M

28.55%11.24M

2.55%7.7M

-Accounts payable

-77.54%2.33M

43.62%13.91M

-22.65%12.93M

-51.75%9.16M

-7.87%10.36M

25.73%9.68M

41.35%16.72M

34.35%18.98M

28.55%11.24M

2.55%7.7M

Contract liabilities

-61.75%646.11K

11.23%2.48M

64.67%6.1M

-79.88%2.21M

-88.27%1.69M

-84.88%2.23M

36.86%3.71M

329.51%10.99M

-43.21%14.4M

-40.10%14.73M

Advance receipts

----

-66.67%37.43K

698.96%1.05M

--74.86K

--93.58K

--112.29K

--131.01K

----

Salaries payable

-16.59%3.55M

-10.31%3.22M

-8.40%2.62M

-0.34%6.04M

3.00%4.25M

15.88%3.59M

26.41%2.86M

8.26%6.06M

15.36%4.13M

1.88%3.09M

Taxs payable

-43.74%4.97M

-55.94%3.41M

-41.40%4M

-56.69%7.45M

-47.07%8.83M

-43.26%7.74M

-34.77%6.82M

43.46%17.21M

44.87%16.68M

64.74%13.65M

Other payable (including interest and dividends)

-30.64%8.84M

0.98%12.27M

-48.72%9.46M

-16.08%18.78M

-8.63%12.74M

22.18%12.15M

65.52%18.45M

33.14%22.38M

-25.61%13.95M

-12.75%9.94M

-Other payable

----

0.98%12.27M

----

22.18%12.15M

----

33.14%22.38M

----

-12.75%9.94M

Other current liabilities

-98.25%79.38K

-61.60%2.37M

-3.16%6.45M

-35.46%4.65M

17.53%4.54M

18.53%6.16M

-22.59%6.66M

25.93%7.2M

17.18%3.86M

62.60%5.2M

Total current liabilities

-51.98%20.41M

-9.60%37.65M

-24.81%41.6M

-40.52%49.34M

-33.88%42.49M

-23.33%41.64M

-18.71%55.33M

-5.65%82.95M

-37.21%64.27M

-39.05%54.32M

Current liabilities

Deferred tax liabilities

0.17%34.8M

0.07%34.77M

0.16%34.8M

0.23%34.83M

0.00%34.75M

Long term deferred income

-28.27%319.03K

-26.41%350.47K

-24.77%381.91K

-23.33%413.35K

-22.04%444.79K

-20.89%476.22K

170.17%507.66K

174.73%539.1K

178.92%570.54K

182.78%601.98K

Total non current liabilities

-0.19%35.12M

-0.29%35.12M

-0.20%35.18M

-0.13%35.24M

-0.36%35.19M

-0.36%35.22M

0.92%35.25M

0.98%35.29M

1.05%35.32M

1.11%35.35M

Total liabilities

-28.52%55.53M

-5.33%72.77M

-15.23%76.79M

-28.46%84.58M

-21.99%77.69M

-14.27%76.87M

-12.05%90.59M

-3.76%118.23M

-27.47%99.58M

-27.74%89.66M

Shareholders equity

Paid-in capital

0.00%507.51M

Capital reserve funds

1.47%123.65M

0.20%123.65M

-1.25%121.86M

0.00%123.41M

Surplus reserve funds

0.00%27.22M

Retained profit

-13.75%82.1M

-4.11%84.89M

33.13%109.78M

48.83%104.6M

95.84%95.18M

153.38%88.53M

185.55%82.46M

166.77%70.28M

65.54%48.6M

20.26%34.94M

Shareholders equity without minority interests

-1.50%740.48M

-0.25%743.28M

3.72%768.17M

4.75%762.98M

6.37%751.78M

7.51%745.12M

7.80%740.6M

6.42%728.42M

2.80%706.74M

0.86%693.08M

Total shareholder equity

-1.50%740.48M

-0.25%743.28M

3.72%768.17M

4.75%762.98M

6.37%751.78M

7.51%745.12M

7.80%740.6M

6.42%728.42M

2.80%706.74M

0.86%693.08M

Total liabilityies and equity

-4.03%796.01M

-0.72%816.05M

1.66%844.95M

0.11%847.56M

2.87%829.46M

5.01%821.99M

5.21%831.19M

4.87%846.65M

-2.24%806.33M

-3.52%782.74M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Zhonghua Certified Public Accountants (Special General Partnership)

ZTE Accounting firm (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	105.30%216.89M	-19.54%171.52M	-34.87%118.5M	-27.39%133.51M	-48.89%105.65M	3.21%213.16M	-20.67%181.96M	-23.20%183.86M	-2.75%206.72M	5.89%206.52M
Transactional financial assets	-55.48%80.13M	133.60%140.16M	340.75%220.37M	298.98%200.53M	--180M	--60M	--50M	--50.26M	----	----
Notes receivable and accounts receivable	-27.11%102.5M	-25.95%111.02M	-36.28%115.57M	-32.57%125.44M	-7.86%140.62M	21.80%149.92M	35.92%181.38M	44.35%186.03M	-4.36%152.61M	-17.52%123.09M
-Notes receivable	-39.04%9.02M	-30.45%12M	-36.17%21.92M	-30.36%27.86M	-40.18%14.8M	-20.34%17.25M	26.50%34.33M	24.98%40.01M	-49.51%24.75M	-49.85%21.65M
-Accounts receivable	-25.70%93.48M	-25.36%99.02M	-36.31%93.66M	-33.17%97.58M	-1.61%125.81M	30.79%132.67M	38.32%147.04M	50.75%146.03M	15.66%127.87M	-4.35%101.44M
Other receivables (including interest and dividends)	59.77%2.52M	314.35%6.65M	-15.05%3.72M	-35.81%2M	-21.45%1.58M	-75.42%1.6M	81.32%4.38M	-23.88%3.12M	-51.91%2.01M	-38.86%6.53M
-Other receivable	----	314.35%6.65M	----	----	----	-75.42%1.6M	----	-23.88%3.12M	----	-38.86%6.53M
Advance payment	9.34%24.96M	-90.15%2.3M	12.89%14.81M	-66.06%4.37M	-50.69%22.83M	38.65%23.32M	42.98%13.12M	9.98%12.88M	97.53%46.3M	-4.05%16.82M
Inventories	-5.30%87.16M	20.30%97.43M	7.80%89.94M	2.81%84.6M	17.89%92.04M	-6.61%80.99M	5.37%83.44M	12.17%82.28M	0.52%78.07M	4.26%86.72M
Receivable financing	-70.87%4.11M	-40.00%8.56M	-38.12%19.82M	-25.86%28.6M	-37.08%14.1M	-21.59%14.27M	27.32%32.03M	24.26%38.58M	--22.4M	--18.2M
Other current assets	-83.82%340.93K	-28.42%1.61M	-71.76%492.24K	170.44%1.11M	4,770.97%2.11M	-88.77%2.25M	695.14%1.74M	-65.44%411.65K	-95.23%43.25K	2,010.93%20.05M
Total current assets	-7.21%518.61M	-1.15%539.25M	6.42%583.24M	4.08%580.17M	9.99%558.92M	14.14%545.53M	14.42%548.05M	13.84%557.43M	6.24%508.16M	4.67%477.93M
Non Current assets
Long-term equity investment	-6.83%24.3M	-4.86%25.31M	-8.12%26.13M	-7.78%27.09M	-13.17%26.08M	-13.22%26.61M	-6.94%28.44M	-3.96%29.38M	-42.74%30.03M	-43.76%30.66M
Fixed assets	----	-8.67%181.06M	----	----	----	-7.48%198.25M	----	-9.14%203.7M	----	-8.35%214.28M
Constru in process	----	--6.71M	----	----	----	----	----	----	----	----
Intangible assets	-3.44%46.3M	-5.81%46.55M	-7.89%46.88M	-9.86%47.21M	-10.97%47.95M	-10.67%49.42M	-10.41%50.9M	-10.15%52.37M	-9.89%53.85M	-9.52%55.33M
Long deferred expense	--469.4K	--190.77K	----	----	----	----	----	----	----	----
Deferred tax assets	12.14%2.44M	16.81%2.55M	-2.17%2.17M	-1.31%2.19M	-51.75%2.18M	-51.81%2.19M	-51.31%2.21M	-51.79%2.21M	-13.46%4.52M	-12.68%4.54M
Other non current assets	--7.44M	--14.42M	-70.97%430.2K	-68.14%493.2K	----	----	--1.48M	--1.55M	----	--0
Total non current assets	2.54%277.41M	0.12%276.79M	-7.57%261.71M	-7.55%267.39M	-9.26%270.55M	-9.30%276.46M	-8.97%283.14M	-8.95%289.22M	-13.94%298.17M	-14.06%304.81M
Total assets	-4.03%796.01M	-0.72%816.05M	1.66%844.95M	0.11%847.56M	2.87%829.46M	5.01%821.99M	5.21%831.19M	4.87%846.65M	-2.24%806.33M	-3.52%782.74M
Liabilities
Current liabilities
Short term loan	----	----	----	----	----	----	----	----	----	--0
Notes payable and accounts payable	-77.54%2.33M	43.62%13.91M	-22.65%12.93M	-51.75%9.16M	-7.87%10.36M	25.73%9.68M	41.35%16.72M	34.35%18.98M	28.55%11.24M	2.55%7.7M
-Accounts payable	-77.54%2.33M	43.62%13.91M	-22.65%12.93M	-51.75%9.16M	-7.87%10.36M	25.73%9.68M	41.35%16.72M	34.35%18.98M	28.55%11.24M	2.55%7.7M
Contract liabilities	-61.75%646.11K	11.23%2.48M	64.67%6.1M	-79.88%2.21M	-88.27%1.69M	-84.88%2.23M	36.86%3.71M	329.51%10.99M	-43.21%14.4M	-40.10%14.73M
Advance receipts	----	----	-66.67%37.43K	698.96%1.05M	--74.86K	--93.58K	--112.29K	--131.01K	----	----
Salaries payable	-16.59%3.55M	-10.31%3.22M	-8.40%2.62M	-0.34%6.04M	3.00%4.25M	15.88%3.59M	26.41%2.86M	8.26%6.06M	15.36%4.13M	1.88%3.09M
Taxs payable	-43.74%4.97M	-55.94%3.41M	-41.40%4M	-56.69%7.45M	-47.07%8.83M	-43.26%7.74M	-34.77%6.82M	43.46%17.21M	44.87%16.68M	64.74%13.65M
Other payable (including interest and dividends)	-30.64%8.84M	0.98%12.27M	-48.72%9.46M	-16.08%18.78M	-8.63%12.74M	22.18%12.15M	65.52%18.45M	33.14%22.38M	-25.61%13.95M	-12.75%9.94M
-Other payable	----	0.98%12.27M	----	----	----	22.18%12.15M	----	33.14%22.38M	----	-12.75%9.94M
Other current liabilities	-98.25%79.38K	-61.60%2.37M	-3.16%6.45M	-35.46%4.65M	17.53%4.54M	18.53%6.16M	-22.59%6.66M	25.93%7.2M	17.18%3.86M	62.60%5.2M
Total current liabilities	-51.98%20.41M	-9.60%37.65M	-24.81%41.6M	-40.52%49.34M	-33.88%42.49M	-23.33%41.64M	-18.71%55.33M	-5.65%82.95M	-37.21%64.27M	-39.05%54.32M
Current liabilities
Deferred tax liabilities	0.17%34.8M	0.07%34.77M	0.16%34.8M	0.23%34.83M	0.00%34.75M	0.00%34.75M	0.00%34.75M	0.00%34.75M	0.00%34.75M	0.00%34.75M
Long term deferred income	-28.27%319.03K	-26.41%350.47K	-24.77%381.91K	-23.33%413.35K	-22.04%444.79K	-20.89%476.22K	170.17%507.66K	174.73%539.1K	178.92%570.54K	182.78%601.98K
Total non current liabilities	-0.19%35.12M	-0.29%35.12M	-0.20%35.18M	-0.13%35.24M	-0.36%35.19M	-0.36%35.22M	0.92%35.25M	0.98%35.29M	1.05%35.32M	1.11%35.35M
Total liabilities	-28.52%55.53M	-5.33%72.77M	-15.23%76.79M	-28.46%84.58M	-21.99%77.69M	-14.27%76.87M	-12.05%90.59M	-3.76%118.23M	-27.47%99.58M	-27.74%89.66M
Shareholders equity
Paid-in capital	0.00%507.51M	0.00%507.51M	0.00%507.51M	0.00%507.51M	0.00%507.51M	0.00%507.51M	0.00%507.51M	0.00%507.51M	0.00%507.51M	0.00%507.51M
Capital reserve funds	1.47%123.65M	1.47%123.65M	0.20%123.65M	0.20%123.65M	-1.25%121.86M	-1.25%121.86M	0.00%123.41M	0.00%123.41M	0.00%123.41M	0.00%123.41M
Surplus reserve funds	0.00%27.22M	0.00%27.22M	0.00%27.22M	0.00%27.22M	0.00%27.22M	0.00%27.22M	0.00%27.22M	0.00%27.22M	0.00%27.22M	0.00%27.22M
Retained profit	-13.75%82.1M	-4.11%84.89M	33.13%109.78M	48.83%104.6M	95.84%95.18M	153.38%88.53M	185.55%82.46M	166.77%70.28M	65.54%48.6M	20.26%34.94M
Shareholders equity without minority interests	-1.50%740.48M	-0.25%743.28M	3.72%768.17M	4.75%762.98M	6.37%751.78M	7.51%745.12M	7.80%740.6M	6.42%728.42M	2.80%706.74M	0.86%693.08M
Total shareholder equity	-1.50%740.48M	-0.25%743.28M	3.72%768.17M	4.75%762.98M	6.37%751.78M	7.51%745.12M	7.80%740.6M	6.42%728.42M	2.80%706.74M	0.86%693.08M
Total liabilityies and equity	-4.03%796.01M	-0.72%816.05M	1.66%844.95M	0.11%847.56M	2.87%829.46M	5.01%821.99M	5.21%831.19M	4.87%846.65M	-2.24%806.33M	-3.52%782.74M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Zhonghua Certified Public Accountants (Special General Partnership)	--	--	--	ZTE Accounting firm (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

002198 Guangdong Jiaying Pharmaceutical

Guangdong Jiaying Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target